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Psychotic disorders, particularly of the schizophrenia-
spectrum, are among the most severe mental diseases. They
can lead to delays in the maturation of neuropsychological
functions in affected children and adolescents and long-
term neuropsychological deficits [1, 2] as well as signifi-
cant impairments in psychosocial functioning [3]. This
makes schizophrenia one of the six leading causes of years
lived with disability [4]. To fight the devastating conse-
quences of psychotic disorders, two strategies have been
followed with great enthusiasm and hope over the last
15 years.
One strategy is to detect the disorder as early as possi-
ble, i.e., to reduce the duration of untreated psychosis and,
consequently, to adequately treat the disorder as soon as
possible with an early and specialized intervention. Nota-
bly, it was assumed for a long time that an adolescent onset
of psychosis (before age 18, EOP) is associated with worse
outcomes compared to adult-onset psychosis (AOP; [5]).
However, two recent studies comparing EOP (age 14–17)
with AOP (age 18–30) did not support this assumption.
They indicated that EOP when also treated in an early
psychosis, prevention and intervention centre have similar
short-term [6] and similar or even better long-term out-
comes [7]. Most recently, an independent comparative
population based study conducted in a different centre
confirmed these findings [8]. It still remains to be shown
whether specialized early detection and intervention indeed
causes the similar or even better outcomes of EOP. Despite
the face validity of early intervention, it is not yet clear for
patients with AOP that early intervention is superior to
treatment-as-usual for patients with AOP. A recent Coch-
rane review concluded that there is some support for the
superior effectiveness of early intervention, but that further
studies are desirable, and that it is questionable whether
gains are maintained [9]. Regarding early intervention
strategies, it is generally recommended that an early
intervention service should be provided longer than 2 years
[10] or, alternatively, new strategies should be developed
to produce more sustainable effects of short-term intensive
early intervention programs. For children and adolescents
with EOP, studies on the effectiveness of such programs or
special needs within these programs are necessary. While
initial evidence suggests that early intervention works in
adolescents [7], the duration of untreated psychosis was
found to be clearly longer in adolescents than in adults
despite early detection efforts [11, 12]. However, the rea-
sons for this are not known. Potential reasons are: insuffi-
cient knowledge about psychotic symptoms in the
respective health care service (including child and ado-
lescent psychiatry/psychology); a more insidious onset of
symptoms; more negative symptoms; higher rates of refu-
sal to seek help, and overlooking symptoms or misinter-
preting them as adolescent crisis by parents and teachers.
The second strategy to improve outcome of psychotic
disorders is to detect early signs of the emerging disorder
before sustained psychotic symptoms occur. While a pro-
drome may include rather unspecific symptoms and can
only safely be diagnosed in retrospect, research over the
last 15 years has brought about two rather specific sets of
at-risk criteria for psychotic disorders, the ultra-high risk
criteria (including attenuated psychotic symptoms, APS;
brief limited intermittent symptoms, BLIPS) and the basic
symptom criteria (including cognitive–perceptive symp-
toms, COPER; cognitive disturbances, COGDIS). The
presence of one of these criteria is associated with an about
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20 % risk of conversion to psychosis in help-seeking adults
in the following year [13]. This research, in mostly adult
samples, led to the proposal of an Attenuated Psychosis
Syndrome for inclusion in DSM-5 [14]. In this journal,
1 year ago, Arango [15] carefully weighed the risks and
benefits for children and adolescents of including the
Attenuated Psychosis Syndrome in DSM-5, and made the
point that APS must also be considered in developmental
terms. APS are not sufficiently validated in children and
adolescents in terms of conversion to psychosis or disease
status at all. As the Attenuated Psychosis Syndrome
includes only one out of three UHR and none of the basic
symptom criteria, future research on the early detection of
psychosis in children and adolescents must take a broader
perspective. The following questions should be addressed:
1. Predictive validity of current at-risk criteria in chil-
dren and adolescents: To date, only two rather small
studies assessed conversion rates exclusively in chil-
dren and adolescents. Cornblatt [16] (48, 12- to
18-year-old, adolescents with attenuated psychotic
symptoms) reported that at-risk adolescents converted
to psychosis later than expected from studies of adults.
However, Ziermans [17] (58, 12- to 18-year-old,
adolescents with UHR criteria or COGDIS) reported
that the conversion rate was slightly lower but not
delayed compared to adults (16 % in 2 years). Data on
children below age 12 are not available.
2. Assessment issues: Apart from the schizophrenia
proneness instrument–child and youth version (SPI–
CY; [18]) for the assessment of basic symptoms in
children and adolescents (age 8–17), no age-adapted
tools for the assessment of the other at-risk criteria in
children and adolescents exist. As most studies on
adults included some adolescents (Cage 15), it is
probably safe to use current assessment tools in this
age group (e.g., SIPS [19] or CAARMS [20]);
whereas, it is not known whether at-risk criteria are
valid in this age group. However, it is unclear (1) at
what age children are able to provide reliable account
of at-risk symptoms, (2) when and how parental
reports should be considered, and (3) how a differential
diagnosis to relevant child and adolescent psychiatric
disorders should be made (e.g., autism spectrum
disorders).
3. Significance of at-risk symptoms in the general pop-
ulation of children and adolescents: To date, it is not
fully understood whether at-risk symptoms are so
common among children and adolescents that a valid
distinction between ill and non-ill youngsters is
difficult [21]. This question came into focus with
several studies in adults and children that report high
rates of standardized lay person or self-report assessed
psychotic-like experiences in the general population
[15]. However, only three studies addressed this
question to date in adults [22] and adolescents
[3, 23] using appropriate clinical assessments of at-
risk criteria. All the three studies found rather low rates
of APS or BLIPS in children (age 11–13; 0.9–8.1 %
depending on UHR definition [23]) or adults (age
16–40; 0–2 % [22]) as well as COPER (\3 %) and
COGDIS (\8.0 %) in adolescents [13]. Notably, in
children and adolescents, 63 % of adolescents with
APS or BLIPS met criteria for at least one past or
present axis-I diagnosis according to DSM-IV [23].
They also had poorer psychosocial functioning than
the control group. In the pilot-study on adults, similar
findings were reported [22]. These rather preliminary
findings support the notion that current at-risk criteria,
if carefully assessed, are less prevalent than expected
from studies on psychotic-like experiences and related
to some impairment. Furthermore, the clinical rele-
vance of (atypical) psychotic symptoms in children
and their predictive validity for a psychotic disorder is
still not fully understood. While several studies
confirm the transient and atypical nature of (atypical)
psychotic symptoms in children with low conversion
rates to psychotic disorders [24–26], the Dunedin birth
cohort study reported that psychotic symptoms at age
11 predicted the emergence of a schizophreniform
disorder at age 26, but also of an anxiety disorder [27].
Regarding clinical implications, child and adolescent
psychiatry is far from having a sufficient evidence base for
creating appropriate strategies for the early detection and
early intervention in psychosis in this age group. However,
regarding early intervention, initial evidence suggests that
adolescents (age 14–17) benefit from early intervention
programs to a degree that is comparable to the benefit of
young adults [6, 7]. Yet, age-appropriate early detection
strategies may be necessary to reduce the duration of
untreated psychosis in adolescents. The early detection of
psychosis in the prodromal stage is difficult in both adults
and children/adolescents. However, the proposal of an
Attenuated Psychosis Syndrome for inclusion in DSM-5
reflects the fact that patients with APS indeed experience
distress and significant impairment, so that treatment seems
justified independent of conversion risk to psychosis.
While the evidence is sparse, our experience is that this
may also be true in children and adolescents. They (and
their parents or carers) suffer from at-risk symptoms,
appreciate their competent assessment and are interested in
focusing on them in the treatment process, independent of
conversion risk. The concern that an increased use of
antipsychotics in children and adolescents might follow the
introduction of a non-validated Attenuated Psychosis
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Syndrome, voiced by Arango [15], may be true. However,
the availability of a child and adolescent psychiatrist with
special training and sufficient experience in the assessment
of at-risk symptoms in this age group will be most wel-
comed in the mental health system. This would prevent an
unjustified and potentially stigmatizing, yet commonly
encountered pseudo-diagnosis of ‘‘pre-psychotic’’ or
‘‘prodromal’’ for these patients, and may thereby limit
premature or prolonged use of antipsychotics. To this, it is
recommended that adult and child and adolescent psychi-
atrists work together in a team and that the clinical sig-
nificance and predictive validity of current at-risk criteria
in children and adolescents is further studied.
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